Healthcare -
Biotechnology - NASDAQ - US
$ 3.3
-3.11 %
$ 127 M
Market Cap
-2.09
P/E
TARA - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities TARA - Protara Therapeutics, Inc.
19.2 M
LAST VALUE
13.19%
2 YEAR CAGR
50.46%
5 YEAR CAGR
13.46%
10 YEAR CAGR